Elanco Animal Health Incorporated Tax Withholding Paid on Stock Awards
Elanco Animal Health Incorporated (ELAN) reported Tax Withholding Paid on Stock Awards of $35.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- Elanco Animal Health Incorporated payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $1.00M, a 0.00% change year-over-year.
- Elanco Animal Health Incorporated payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $34.00M, a 161.54% increase year-over-year.
- Elanco Animal Health Incorporated payment, tax withholding, share-based payment arrangement for the quarter ending 2025-06-30 was $1.00M.
- Elanco Animal Health Incorporated payment, tax withholding, share-based payment arrangement for the quarter ending 2025-03-31 was $13.00M.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month |
|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $35.00M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $34.00M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $14.00M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $13.00M 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |